Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC104534.3 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | KANK3 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | NOTCH2NL | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-06 |
mRNA | TNPO2 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | PIK3C3 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | CAMK2B | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | CELSR3 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | VASH1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | CTDP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |